文献速递糖尿病

1型糖尿病微血管并发症与心血管疾病风险的关联

Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes.
PubMed 文献 · Diabetes Care · 2021-05-12

在DCCT/EDIC队列随访超过35年的1型糖尿病患者中,微血管病变(视网膜病变、肾脏病变或心脏自主神经病变)与后续心血管疾病(CVD)和主要不良心血管事件(MACE)风险增加相关(HR分别为1.86-3.18和2.09-3.63),调整年龄和HbA1c后仍显著。但调整传统CVD危险因素后,仅持续AER≥30 mg/24h(单独或合并eGFR<60 mL/min/1.73m2)以及同时存在视网膜和肾脏病变仍与CVD相关。

要点

  • 微血管病变与1型糖尿病CVD风险增加相关,HR 1.86-3.18。
  • 持续白蛋白尿≥30 mg/24h或eGFR<60者CVD风险持续升高。
  • 视网膜病变合并肾脏病变与CVD风险独立相关。

核心结论

  • 晚期微血管病变,尤其是中度至重度白蛋白尿或eGFR<60 mL/min/1.73m2,与1型糖尿病患者后续心血管疾病风险增加相关。

研究设计与样本

  • 研究基于DCCT/EDIC队列,对1型糖尿病患者随访超过35年,采用标准化纵向数据收集,包括视网膜病变分期、尿白蛋白排泄率(AER)、eGFR、心脏自主神经病变(CAN)反射测试及 adjudicated CVD事件。
  • 使用Cox比例风险模型评估微血管并发症与后续CVD风险的关联。

主要发现

  • 共有239名参与者发生CVD,其中120名发生主要不良心血管事件(MACE,定义为非致死性心肌梗死、非致死性卒中或心血管死亡)。
  • 微血管病变(糖尿病视网膜病变、肾脏疾病或CAN)与后续CVD和MACE风险增加相关,风险比分别为1.86至3.18和2.09至3.63,调整年龄和HbA1c后仍显著。
  • 调整传统CVD危险因素后,仅持续AER≥30 mg/24h(单独或合并eGFR<60 mL/min/1.73m2)以及同时存在视网膜和肾脏病变仍与CVD相关。

关键数值与推荐

  • 微血管病变与CVD风险关联的风险比范围为1.86至3.18。
  • 微血管病变与MACE风险关联的风险比范围为2.09至3.63。
  • 持续AER≥30 mg/24h和/或eGFR<60 mL/min/1.73m2与CVD风险相关。
  • 同时存在视网膜病变和肾脏病变与CVD风险相关。

临床怎么用

  • 对1型糖尿病患者应关注微血管并发症,特别是持续白蛋白尿和eGFR降低,以评估心血管疾病风险。
  • 视网膜病变合并肾脏病变提示CVD风险增加,需加强心血管风险管理。

局限性

  • 研究基于DCCT/EDIC队列,结果可能受队列特征影响,推广需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We examined whether the presence of microvascular complications was associated with increased subsequent risk of cardiovascular disease (CVD) among participants with type 1 diabetes in the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study followed for >35 years. RESEARCH DESIGN AND METHODS: Standardized longitudinal data collection included: 1) stereoscopic seven-field retinal fundus photography centrally graded for retinopathy stage and clinically significant macular edema; 2) urinary albumin excretion rate (AER) and estimated glomerular filtration rate (eGFR); 3) cardiovascular autonomic neuropathy (CAN) reflex testing; and 4) adjudicated CVD events, including death from CVD, nonfatal myocardial infarction, stroke, subclinical myocardial infarction on electrocardiogram, confirmed angina, or coronary artery revascularization. Cox proportional hazards models assessed the association of microvascular complications with subsequent risk of CVD. RESULTS: A total of 239 participants developed CVD, including 120 participants who suffered major adverse cardiovascular events (MACE) defined as nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death. The presence of microvascular disease (diabetic retinopathy, kidney disease, or CAN) was associated with increased risk of subsequent CVD and MACE (hazard ratios 1.86 to 3.18 and 2.09 to 3.63, respectively), associations that remained significant after adjusting for age and HbA1c. After adjustment for traditional CVD risk factors, however, only sustained AER ≥30 mg/24 h occurring alone and/or with eGFR <60 mL/min/1.73 m2 and the presence of both retinal and kidney disease remained associated with CVD. CONCLUSIONS: Advanced microvascular disease, especially moderate to severe albuminuria or eGFR <60 mL/min/1.73 m2, conveyed an increased risk of subsequent cardiovascular disease in the DCCT/EDIC cohort.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Gubitosi-Klug R, Gao X, Pop-Busui R, et al. Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes Care. 2021. PMID: 33980605. doi:10.2337/dc20-3104

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。